Lila Cherry
Physical Medicine & Rehabilitation · Lufkin, TXNPI 1922065085
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $961 and has fallen 80.9% since, to $184 in 2025.
Across 181 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$515
- Supernus Pharmaceuticals, Inc.$274
- SK Life Science, Inc.$247
- Jazz Pharmaceuticals Inc.$214
- Greenwich Biosciences, Inc.$206
- Lilly USA, LLC$172
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$341%
- Food & beverage$3,01599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $515 |
| Supernus Pharmaceuticals, Inc. | 18 | $274 |
| SK Life Science, Inc. | 14 | $247 |
| Jazz Pharmaceuticals Inc. | 9 | $214 |
| Greenwich Biosciences, Inc. | 13 | $206 |
| Lilly USA, LLC | 12 | $172 |
| Amgen | 9 | $172 |
| Sunovion Pharmaceuticals Inc. | 11 | $164 |
| UCB, Inc. | 8 | $147 |
| Amneal Pharmaceuticals LLC | 8 | $114 |
| Kyowa Kirin, Inc. | 6 | $114 |
| Aquestive Therapeutics, Inc. | 5 | $98 |
| Eisai Inc. | 6 | $94 |
| Novartis | 5 | $92 |
| Boston Scientific | 1 | $79 |
| Sanofi | 4 | $78 |
| CSL Behring | 3 | $57 |
| Medtronic | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Acorda Therapeutics, Inc | 2 | $34 |
| Neurelis, Inc. | 2 | $34 |
| Biogen | 1 | $17 |
| Argenx US, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Lundbeck LLC | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,049 in reported general payments places this provider in the 85th percentile of 651 physical medicine & rehabilitation providers in Texas.
See all physical medicine & rehabilitation providers in Texas →
Other physical medicine & rehabilitation in Lufkin
- Gerard FranciscoHouston$364K
- Jose UrquidezAustin$332K
- Gireesh ShardaDallas$172K
- Suzanne ManziHouston$143K
- Cindy IvanhoeHouston$111K
- Chad McNeilTyler$64K
- Sheng LiHouston$44K
- Mary RussellShenandoah$37K
- Randall WolcottLubbock$31K
- Ryan WhitmerCollege Station$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.